ilomastat has been researched along with arginyl-glycyl-aspartic acid in 2 studies
Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
---|---|---|---|---|---|
103 | 0 | 45 | 4,556 | 17 | 1,799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archer, L; Dolce, C; Holliday, LS; Vakani, A | 1 |
Hur, MA; Laforest, R; Lapi, SE; Mebrahtu, E; Zheleznyak, A | 1 |
2 other study(ies) available for ilomastat and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement.
Topics: Amides; Amino Acid Sequence; Analysis of Variance; Animals; Bone Marrow Cells; Bone Remodeling; Bone Resorption; Cell Culture Techniques; Delayed-Action Preparations; Hydroxamic Acids; Indoles; Male; Matrix Metalloproteinase Inhibitors; Maxilla; Mice; Oligopeptides; Osteoclasts; Polyvinyls; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Tooth Movement Techniques; Tyrosine | 2003 |
Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity.
Topics: Amino Acid Sequence; Cell Line, Tumor; Copper Radioisotopes; Drug Stability; Enzyme Assays; Heterocyclic Compounds, 1-Ring; Humans; Hydroxamic Acids; Indoles; Integrin alphaVbeta3; Iodine Radioisotopes; Isotope Labeling; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Multimodal Imaging; Oligopeptides; Phantoms, Imaging; Positron-Emission Tomography; Proteolysis; Time Factors; Tomography, X-Ray Computed | 2013 |